Now that definitive direct evidence has been obtained that oxidized me
tabolites of catecholamines - aminochrome (derived from dopamine) and
related compounds - occur in the human brain the question this paper e
xplores is what is their function there, if any. They are precursors o
f neuromelanin and are formed inter alia by co-oxidation by prostaglan
din H synthase during the synthesis of prostaglandin Il from arachidon
ic acid. Their further metabolism by NAHPD-cytochrome P450 reductase f
orms the highly neurotoxic o-semiquinone together with free oxygen rad
icals. The defenses against these orthoquinones (o-quinones) and o-sem
iquinones (which include reduction, O-methylation, 5-cysteinylization,
glutathione conjugation, conversion to the o-hydroquinone, and neurom
elanin formation), and their possible status in schizophrenia, are rev
iewed. This system is closely linked with glutamate neurotoxicity beca
use glutamate receptors activate PGH synthase and because dopamine tox
icity is mediated by these o-quinones acting on NMDA receptors. Intera
ctions between glutamate and dopamine neurotoxicity are explored, incl
uding a possible role for the redox properties of catecholamines. The
hypothesis is presented that some of the demonstrated cellular damage
in the schizophrenic brain may be mediated by catecholamine o-quinones
. The significance of the evidence from previous studies carried out 4
0 years ago, that a closely related catecholamine o-quinone - adrenoch
rome - has psychotomimetic properties in humans and behavior disruptin
g properties in animals, is reviewed in the light of these recent find
ings.